Literature DB >> 20454984

Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.

B Szende1, G Barna, Kálmán Magyar.   

Abstract

Postulated cytoprotective action of (-)-deprenyl (D), (-)-desmethyl-deprenyl (DD) and (-)-deprenyl-N-oxide (DNO) on L-buthionine-(S,R)-sulfoximine (BSO) toxicity was investigated using in vitro cultures of serum-deprived A-2058 melanoma cells. BSO (10 microM/l) decreased viable cell number and mitotic rate, while increased the apoptotic index. D and both of its metabolites, given together with BSO in the concentration of 50 microM/l, mitigated cell loss and decreased the apoptotic ratio. DD was the most effective compound in decreasing apoptotic activity, while DNO stabilized the cell number on control level and increasing the ratio of mitotic cells above the only serum-deprived control. Surveillance on mitochondrial membrane stability and antioxidant properties may play an important role in these processes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20454984     DOI: 10.1007/s00702-010-0413-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  19 in total

1.  The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo.

Authors:  M B Youdim; A Wadia; W Tatton; M Weinstock
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

2.  Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress.

Authors:  J Mårtensson; A Jain; E Stole; W Frayer; P A Auld; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

3.  A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry.

Authors:  J Gong; F Traganos; Z Darzynkiewicz
Journal:  Anal Biochem       Date:  1994-05-01       Impact factor: 3.365

4.  Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites.

Authors:  B Szende; G Bökönyi; J Bocsi; G Kéri; F Timár; K Magyar
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

5.  Reduction of tertiary amine N-oxides by rat liver mitochondria.

Authors:  M Sugiura; R Kato
Journal:  J Pharmacol Exp Ther       Date:  1977-01       Impact factor: 4.030

6.  Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion.

Authors:  C Mytilineou; E K Leonardi; P Radcliffe; E H Heinonen; S K Han; P Werner; G Cohen; C W Olanow
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

7.  Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells.

Authors:  W G Tatton; R M E Chalmers-Redman; W J H Ju; M Mammen; G W Carlile; A W Pong; N A Tatton
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

Review 8.  Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration.

Authors:  W G Tatton; R M Chalmers-Redman
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

9.  Pharmacokinetic studies of (-)-deprenyl and some of its metabolites in mouse.

Authors:  K Magyar; I Szatmáry; G Szebeni; J Lengyel
Journal:  J Neural Transm Suppl       Date:  2007

10.  (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis.

Authors:  W G Tatton; W Y Ju; D P Holland; C Tai; M Kwan
Journal:  J Neurochem       Date:  1994-10       Impact factor: 5.372

View more
  1 in total

1.  Basic cell physiological activities (cell adhesion, chemotaxis and proliferation) induced by selegiline and its derivatives in Mono Mac 6 human monocytes.

Authors:  Eszter Lajkó; Lívia Polgár; Orsolya Láng; József Lengyel; László Kőhidai; Kálmán Magyar
Journal:  J Neural Transm (Vienna)       Date:  2011-11-16       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.